In this issue:
SSAs for Ki-67≥10% pancreatic neuroendocrine tumours
CheckMate 577: adjuvant nivolumab improves DFS in GOJ
Avapritinib for advanced GIST in the fourth-line setting
No benefit to palliative radiotherapy after oesophageal cancer stenting
Pembrolizumab may provide a survival advantage in CPS≥10 gastric/GOJ cancer
Adjuvant radiotherapy extends survival after resection of cholangiocarcinoma
Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer
Similar efficacies for FOLFIRINOX and GnP in metastatic pancreatic cancer
Oxaliplatin-based PIPAC in patients with peritoneal metastases
Afatinib/selumetinib has limited efficacy in KRAS-mutated cancers
Please login below to download this issue (PDF)